Bibliografi: Forskning i homøopati
Klassisk Homøopati
Egebjerg Andersen, H.: En undersøgelse af Klassisk
Homøopati - Teorier, praksis og brugererfaringer.
Den første undersøgelse, der omfatter brugernes evaluering af
virkningen af klassisk homøopatisk behandling udført i Danmark
Rapporten bygger på en undersøgelse af 8 klassiske homøopater,
uddannet på Skolen for Klassisk Homøopati og 345 brugere af
disses behandlinger.
Forord af Michael von Magnus
Kommentarer af Laila Launsø
Udgivet på anbefaling af Sundhedsstyrelsens Råd vedrørende
Alternativ Behandling
Grundforskning
M. Wiesenauer og W. Gaus. 1985;
Double-blind trial comparing the
effectiveness of the homeopathic preparation Galphimia D6 10(-6)
and placebo in pollinosis.
Arzneim-Forsch/Drug res.35 nr. 11,
1985, s. 1745-1747.
Davenas, Benveniste et al.
1988;
Human basophil degranulation
triggered by very dilute antiserum against IgE.
Nature Vol.333, Juni 1988.
Homøopatisk medicin -
energimedicin?
D. Knapp. 1985;
Die bioenergetische Strahlung und
homøopatische Medikamente.
CHK, 2, 1985 s. 74-82.
L. Hadji, B. Arnoax, J.
Benveniste. 1991;
Effect of dilute histamine on
coronary flow of guinea-pig isolated heart. Inhibition by a
magnetic field.
Abstract from FASEB 1991.
Potensvariationer
R. I. Jones, M.D. Jenkins.
1988;
Plant responses to homoeopathic
remedies.
British Homoeopathic Journal 1988;
70:120-8.
G. Harish, M. Kretschmer.
Jenseits vom Milligram.
Springer Verlag, s. 21-41.
G. Harish, M. Kretschmer.
Jenseits vom Milligram.
Die Biochemie auf der Spuren der
Homeôpathie.
Springer Verlag (ISBN 3-540-52424-X)
Biokemiske forsøg med
homøopatisk medicin
E. Davenas, J. Benveniste et al.
1988;
Human basophil degranulation
triggered by dilute antiserum against IgE.
Nature 1988, vol.333, s. 316-318.
B. Poitevin, E. Davenas, J.
Benveniste. 1988;
In vitro degranulation of human
basophils is modulated by lung histamine and Apis Mellifica.
British Jour. of Clinic. Pharmacol.
1988, 25, s. 439-444.
Benveniste, Davenas, Ducot et
al. 1991;
Agitation of highly dilute
solutions does not induce specific biological activity.
C. R. Acad. Scr. Paris t., 1991.
312, Serie II, p. 461-466.
C. Petit, B. Belson, R. Got.
1989;
Effect of homoeopathic dilutions
on subcellular enzymatic activity.
Human Toxocol. 1989, 8, 125-129.
H. Wagner et al.
Die Beeinflussung der
Phagozytosefähigkeit von Granulozyten durch homöopatische
Arzneipräparate.
Arzneim.-Forch./Drug Res. 36(11), 9.
Pedersen P.A. 1972;
Eksperimentel påvisning af
virkninger af potenserede substanser, 14. okt. 1972, nr. 42,
Farmaceutisk Tidende, Dansk Farmaceutforening
Kliniske Undersøgelser 1977-1991
Savage R. H. et al. 1977;
A double blind trial to assess
the benefit from Arnica montana in acute stroke illness.
The British Homeopathic Journal,
Oct. 1977; 207-13.
Gibson et al. 1980;
Homeopathic therapy in rheumatoid
arthritis: Evaluation by a double blind clinical therapeutic
trial.
Br. j. Clin. Pharmacol. 1980, 9;
453-59.
Shipley M. et al. 1983;
Controlled trial of homeopathic
treatment of osteoarthritis.
Lancet. Jan. 15, 1983; 97-98.
Reilly D. T. et al. 1986;
Is homeopathy a placebo response
?
Controlled trial of homeopathic
potency. With pollen in hayfever as a model.
Lancet. Oct. 18. 1986; 881-885.
Mayaux M. J. et al. 1988;
Controlled trial in postoperative
ileus.
Lancet, Mar. 5. 1988; 528-29.
Zell J. et al.
1988;
Treatment of acute sprains of the
ankle. (summary)
Fortchr. Med 106 JG 1988. 96-100.
Fisher P. et al. 1989;
Effect of homeopathic treatment
of fibrositis (primary fibromyalgia).
BMJ, Aug. 5. 1989; 365-366.
Ferly P. et al.
1989;
A controlled trial of a
homeopathic preparation in the treatment of influenza-like
syndrome.
Br. J. Clin. Pharmacol. 1989; 29,
329-35.
Brigo B. et al.
1991;
Homeopathic treatment of
migraines: A randomized double-blind controlled study of sixty
cases (Homeopathic remedy versus placebo).
The Berlin Journal on research in
homoeopathy. March 1991; 2, 98-106.
Tveiten D., Bruseth S.,
Bochgrevink C., Løhne K. 1990;
Effekt av Arnica D 30 ved hård
fysisk anstrengelse. Randomiseret dobbelt-blindforsøg under
Oslo Maraton, 1990.
Tidsskr. Nor. Lægeforen. nr. 30,
1991;111: 3630-1.
Walach, H 1992;
Wissenschaftliche Homöopathische
Arzneimittelprüfung. Doppelblinde crossover-Studie einer
homöopatischen Hochpotenz gegen Placebo, Haug, Heidelberg.
Oversigtsartikler
Tveiten D. og Bruseth S.
1991;
Homeopati - fortid eller del av
fremtidens medisin ?
Tidsskr. Nor. Lægeforen. nr. 30,
1991;111
Kleinen J., Knipschild P.,
Riet G.t. 1991;
Clinical trials of homoeopathy,
British Medical Journal, 1991 Feb.
9; 302(6772): 316 - 23.
Linde K. et al. 1997;
Are the clinical effects of
homoeopathy placebo effects ? A meta-analysis of
placebo-controlled trials. The Lancet vol. 350 september 20,
1997
Biologisk forskning
Infinitesimal-doser: Ultra lave
dosers påvirkning af cellers biologiske aktivitet
Safrit J. T. Belldegrun A.,
Bonavida B. 1993;
Sensitivity of Human Renal Cell
Carcinoma Lines to TNF, Adriamycin, and combination: Role of TNF
mRNA induction in Overcoming Resistance.
The Journal of Urology, 1993, 149:
1202-1208.
Mizutani Y., Bonavida B.
1993;
Overcoming
Cis-Diamminedichloroplatinum (II) Resistance of Human Ovarian
Tumor Cells by combination Treatment with
Cis-Diamminedichloroplatinum (II) and Tumor Necrosis
Factor-Alpha,
Cancer. 1993, 72: 809-818.
Mizutani Y., Bonavida B.
1993;
Overcoming TNF-ox
and CDDP Resistance of a Human Ovarian Cancer Cell Line (C30) by
Treatment with Buthionine Sulfoximine in combination with TNF-ox
and/or CDDP.
International Journal of Oncology,
1993, 3: 229-235.
Safrit J. T., Bonavida B.
1992;
Sensitivity Resistant human Tumor
Cell Lines to Tumor Necrosis Factor and Adriamycin Used in
Combination: Correlation between Down-Regulation of Tumor
Necrosis Factor-Messenger RNA Induction and Overcoming Resistance.
Cancer Research, 1992, 52:
6630-6637.
Safrit J. T. Tsuchitani T.,
Berek J., Zighelboim J., Bonavida B.: 1991;
Overcoming Drug Resistance by the
Synergistic Activity of Drug and Tumor Necrosis Factor, in: New
Frontiers in the Therapy of Malignancies: from Biological
Approaches to Clinical Trials, Ed.
G. Mantovani et al. 1991.
Tsuchitani T., Zighelboim J.,
Berek J., Bonavida B.: 1991;
Potentiation of Cytotoxicity
against Human Ovarian Cell-Lines with Combinations of Subtoxic
Concentrations of Tumor Necrosis Factor and Adriamycin or
Cisplatinum.
Journal Cell. Pharmacol., 1991, 2:
1-11.
Morimoto H., Yonehara S.,
Bonavida B.: 1993;
Overcoming Tumor Necrosis Factor
and Drug Resistance of Human Tumor Cell Lines by Combination
Treatment with Antifas Antibody and Drugs or Toxins.
Cancer Research, 1993, 53:
2591-2596.
Bonavida B.: 1992;
TNF and TNF Receptors: Structure,
Mechanism of Action and Role in Disease and Therapy.
Drugs of Today, 1992, Vol. 28, No.
7: 521-525.
Gan X. H., Jewett A., Bonavida
B.: 1991;
Activation of Human
Peripheral-Blood-Derived Monocytes by
cis-Diamminedichloroplatinum: Enhanced Tumoricidal Activity and
Secretion of Tumor Necrosis Factor-Alpha.
Nat. Immun. Cell. Growth Regul.,
1991, 251.
Bonavida B., Safrit J. T.,
Morimoto H.: 1993;
Reversal of Drug Resistance:
Synergistic Anti-Tumor Cytotoxic Activity by Combination
Treatment with Drug and TNF or Toxins.
Cancer Therapy, 1993, 75: 169-176.
Safrit J. T., Berek J. S.,
Bonavida B.: 1992;
Sensitivity of Drug-Resistant
Human Ovarian Tumor Cell Lines to Combined Effects of Tumor
Necrosis Factor (TNF-ox) and
Doxorubicin: Failure of the Combination to Modulate the MDR
Phenotype.
Gynecologic Oncology, 1992, 48:
214-220.
Morimoto H., Safrit J. T.,
Bonavida B.: 1991;
Synergistic Effect of Tumor
Necrosis and Diphtheria Toxin-Mediated Cytotoxicity in Sensitive
and Resistant Human Ovarian Tumor Cell Lines.
The Journal of Immunology, 1991,
Vol. 147, No. 8: 2609-2616.
Morimoto H., Bonavida B.:
1992;
Diphtheria Toxin- and Pseudomonas
A Toxin- Mediated Apoptosis: ADP Ribosylation of Elongation
Factor-2 is Required for NDA Fragmentation and Cell Lysis and
Synergy with Tumor Necrosis Factor-ox.
The Journal of Immunology, 1992, 49:
2089-2094.
Safrit J. T., Bonavida B.:
1992;
Hierarchy of In Vitro Sensitivity
and Resistance of Tumor Cells to Cytotoxic Effector Cells,
Cytokines, Drugs and Toxins.
Cancer Immunology Immunotherapy,
1992.
Niebauer G. W., Dorci M. et
al. 1980;
Die Wirkung von homöopatischem
Arnica D12 und Actihaemyl auf die Wundheilung im Tierexperiment.
Der praktische Tierartzt 2/ 1980 s.
128-132.
Oberbaum et al (Israel).
1992;
Wound healing by homeopathic
Silica-dilution in mice.
Harefuah 1992 Ang; 123 (3-4); 79-82,
156.
Santini R. Et al. 1991;
Effects of a low-Doses Treatment
With Cuprum on Neostigmine Digestive Action in Female Mice.
Drug Development Research 24:231-233
Fisher P. Et al. 1987;
The influence of the Homoeopathic
Remedy Plumbum Metallicum on the Excretion Kinetics of Lead in
Rats.
Human Toxicol. 6. 321-324
Cazin J. C. 1987;
A study of the effect of Decimal
and Centesimal Dilusions of Arsenic on the Retension and
Mobilization of Arsenic in the Rat.
Human Toxicol. 6. 315-320
Davenas E. Et al. 1987;
Effect on mouse peritoneal
macrophages of orally administered very high dilutions of
Silicea.
European Journal of Pharmacology,
135 (1987) 313-319
Girolami J. P. 1988;
Renal Lallikrein excretion as a
distal nephrotoxicity marker during Cadmium exposure in rats.
Toxicology, 55 (1989) 117-129
Aspirins effekt i infinitesimale
doser
Lalanne M. C., De Seze O.,
Doutremepuich C., Belon P.: 1991;
Could Proteolytic Enzyme Modulate
the Interaction Platelets/Vessel Wall in the Presence of ASA at
Ultra Low Doses ?
Thrombosis Research, 1991, 63:
419-426.
Lalanne M. C., Doutremepuich
C., De Seze O., Belon P.: 1990;
What is the Effect of
Acetylsalicylic Acid at Ultra Low Dose on the Interaction
Platelets/Vessel Wall ?
Thrombosis Research, 1990, 60:
231-236.
Doutremepuich C., De Seze O.,
Le Roy d., Lalanne M. C., Anne M. C.: 1990;
Aspirin at Very Ultra Low Dosage
in Healthy Volunteers: Effects on Bleeding Time, Platelet
Aggregation and Coagulation.
Haemostasis, 1990, 20: 99-105.
Doutremepuich C. Aguejouf O.,
Pintigny D., Sertillanges M. N., De Seze O.:
Thrombogenic Properties of Ultra
Low Dose of Acetylsalicylic Acid in a Vessel Model of Laser
Induced Thrombus Formation, in press.
Doutremepuich C., Paillet d.,
De Seze O., Anne M. C., Paccalin J., Quilichini R.: 1988;
Variation du temps de saignement
après administration à différentes posologies d'acide acetyl
salicylique chez le volontaire sain (= Bleeding Time after
Administration of Acetyl Salicylic Acid in Healthy Volunteers).
Annales Pharmaceutiques Francaises,
1988, 46, No. 1: 35-39.
Vesvres M. H., Doutremepuich
F., Lalanne M. C. L., Doutremepuich C. H. 1993;
Effects of Aspirin on
Embolization in an Arterial Model of Laser-Induced Thrombus
Formation.
Haemostasis, 1993, 23: 8-12.
Doutremepuich C., Paillet D.,
Anne M. C., De Seze O., Paccalin J., Quilichini R.: 1987;
Template Bleeding Time after
Ingestion of Ultra Low Dosages of Acetyle Salicylic Acid in
Healthy Subjects: Preliminary Study.
Thrombosis Research, 1987, 48:
501-504.
Lalanne M. C., Ramboer I., De
Seze O., Doutremepuich C.: 1992;
In Vitro platelets/Endothelial
Cells Interaction is Presence of Acetylsalicylic Acid at Various
Dosages.
Thrombosis Research, 1992, 65:
33-43.
Doutremepuich C., De Seze O.,
Anne M. C., Hariveau E., Quilichini R.: 1987;
Platelet Aggregation on Whole
Blood after Administration of Ultra Low Dosage Acetylsalicylic
Acid in Healthy Volunteers.
Thrombosis Research, 1987, 47:
373-377.
Højpotensers farmakologi:
Sainte-Laudy J., Cherruault Y.,
Papapanaotou C.: 1987;
Analyse mathématique et
modélisation du test de dégranulation (TDBH) (= Mathematical
Analysis and Modelling og the Basophil Degranulation Test (HBDT).
Bio-Sciences, 1987, Vol. 5, No. 6:
210-214.
Sainte-Laudy J.: 1987;
Standardization of Basophil
Degranulation for Pharmaceutical Studies.
Journal of Immunological Methods,
1987, 98: 279-282.
Sainte-Laudy J., Belon P.:
1993;
Inhibition of Human Basophil
Activation by High Dilution of Histamine.
Agents Actions, 1993, 38: C245-C247.
Sainte-Laudy J., Sambucy J.
L., Belon P.: 1991;
Biological Activity of Ultra Low
Doses I/Effect of Ultra Low Doses of Histamine on Human Basophil
Degranulation Triggered by D. Pteronyssinus Extract, in:
Ultra Low Doses, 1991, Taylor &
Francis: 127-138.
Shelley W., Juhlin L.: 1961;
A New Test for Detecting
Anaphylactic Sensitivity: The Basophil Reaction.
Nature, 1961, 191: 1056-1060.
Hadjaj B., Cherruault Y.,
Sainte-Laudy J.: 1993;
Control of Basophil
Degranulation.
Int. i. Biomed. Comput., 1993, 32:
151-159.
Cherruault Y., Guillez A.,
Sainte-Laudy J., Belon P.: 1989;
Etude mathématique et
statistique des effects de dilutions successives de chlorhydrate
d'histamine sur la réactivité des basophiles humains (=
Statistical and Mathematical Study of the Effect of Successive
Dilutions of Histamine Hydrochloride on the Reactivity of Human
Basophils).
Bio-Sciences, 1989, 7: 63-72.
Sainte-Laudy J., Belon P.:
1991;
Biological Activity of Ultra Low
Doses II/Effect of Ultra Low Doses of Histamine on Human Basophil
Degranulation Triggered by Anti-IGE, in:
Ultra Low Doses, 1991, Taylor &
Francis: 139-143.
Papanaotou C., Guellal S.,
Cherruault Y., Belon P., Sainte-Laudy J.: 1987;
Mathematical Analysis and
Modelling in Homeopathy, Proceedings of the Seventh international
Congress of Cybernetics and Systems,
London, 7-11, September 1987.
Belon P.: 1987;
Modelization of the Effect of
Hahnemannian Dilutions on Human Basophil Degranulation,
proceedings of the Seventh International Congress of Cybernetic
and Systems,
London 7-11, September 1987.
Homøopati - Immun-allergologi og
inflammation.
Poitevin B., Aubin M., Benveniste
J.: 1986;
Approche d'une analyse
quantitative de l'effet d'Apis mellifica sur la dégranulation
des basophiles humains in vitro (= Approach to a Quantitative
Analysis of the Effect og Apis Mellifica on in Vitro Human
Basophil Degranulation.
Innov. Tech. Biol. Med., 1986, Vol.
7, No. 1: 64-68.
Poitevin B., Davenas E.,
Benveniste J.: 1988;
In Vitro Immunological
Degranulation of Human Basophils is Modulated by Lung Histamine
and Apis Mellifica.
Br. I. Clin. Pharmac., 1988, 25:
439-444.
Benveniste J., Davenas E.,
Ducot B., Cornillet B., Poitevin B., Spira A.: 1991;
L'agitation de solutions
hautement diluées n'induit pas d'activite biologique spécifique
(= Agitation of Highly Dilute Solutions Does Not Induce Specific
Biological Activity).
C. R. Acad. Scie. Paris, 1991, t.
312, Série II: 461-466.
Davenas E., Beauvais J., Amara
J. et al: 1988;
human Basophil Degranulation
Triggered by Very Dilute Antiserum Against IgE.
Nature, 1988, No. 6176, 333:
616-618.
Ovelgonne J. H., Bol A. W. J.
M., Hop W. C. J., Van Wijck R.: 1992;
Mechanical Agitation of Very
Dilute Antiserum Has No Effect on Basophil Staining Properties.
Experientia, 1992, 48: 504-508.
Fysisk-kemiske mekanismer
Infinitesimal dosers
virkningsmekanisme
Demangeat J. L., Demangeat C.,
Gries P., Poitevin B., Contantinesco A.: 1992;
Modifications des temps de
relaxation RMN à 4 Mhz des protons du solvant dans les très
hautes dilutions salines de silice/lactose (= Modifications of 4
Mhz NMR proton Realization Time sin Very High Dilutions of
Silica/Lactose in Saline).
I. Me. Nucl. Biophy., 1992, 16, 2:
135-145.
Cazin J. C., Cazin M., Chaoui
A., Belon P.: 1991;
Influence of Several Physical
Factors on the Activity of Ultra-Low Doses, in:
Ultra Low Doses, 1991, Taylor &
Francis: 69-80.
Poitevin B.: 1993;
Mécanismes d'action des
médicaments à usage homéopathique. Données récentes et
hypothèses; 1 - Mécanismes physicochimiques. (= Mechanisms of
Action of Medicines for Homeopathic Use. Recent Data and
Hypotheses; 1 - Physical-Chemical Mechanisms).
Homéopathie Eur., 1993, 1: 41-50.
Suslik S. K.: 1988;
Correspondence.
Nature, 1988, 334: 375-376.
Klinisk prøvning
Klinisk prøvning og demonstration
af homøopatiens effekt.
Jacobs J., Jimenz M., Gloyd S.S.,
Gale J. L., Crothers D.: 1994;
Treatment of Acute Childhood
Diarrhea with Homeopathic Medicine: A Randomized Clinical Trial
in Nicaragua.
Pediatrics, 1994, 93: 719-725.
Kleijnen J., Knipschild P.,
Riet G.: 1991;
Clinical Trials of Homeopathy.
British Medical Journal, 1991, 302:
316-323.
Ferley J. P. Zmirou D.,
D'Adhemar D., Balducci F.: 1989;
A Controlled Evaluation of a
Homoeopathic Preparation in the Treatment of Influenza-like
Syndromes.
British Journal of clinical
Pharmacology, 1989, 27: 329-335.
Reilly D. T., Taylor M. A., MC
Sharry C., Aitchison T.: 1986;
Is Homeopathy a Placebo Response
? Controlled Trial of Homeopathic Potency, with Pollen in
Hayfever as Model.
The Lancet, 1986, 881-886.
De Lange De Klerk E. S. M.,
Blommers J., Kuik D. J., Bezemer P. D., Feenstra L.: 1994;
Effect of Homeopathic Medicines
on Daily Burden of Symptoms in Children with Recurrent Upper
Respiratory Tract Infections.
British Medical Journal, 1994, 309:
1329-1332.
Benzecri J. P., Maiti G. D.,
Belon P., Questel R.: 1991;
Comparaison ente quatre methodes
de sevrage après une thérapeutique anxiolytique (= Comparison
between Four Methods of Weaning after Treatment by Minor
Tranquillizers).
Les Cahiers de l'Analyse des
Données, 1991, Vol. XVI, No. 4: 389-402.
Lasveaux L.: 1989;
Traitements homéopath-iques du
choléra dans la France du XIXème siècle (= Homeopathic
Treatments for Cholera in 19th Century France), Collection due
Caducée.
Boiron Ed. Lyon, 1989.
Fisher P.: 1986;
An Experimental Double-blind
Clinical Trial Method in Homeopathy. Use of a Limited Range of
Remedies to Treat Fibrosis.
British Homoeopathic Journal, 1986,
75: 142-147.
Gibson R. G., Gibson S.L.M.,
Mac Neill A. D., Buchanan W.W.: 1980;
The Place for Non-Pharmaceutical
Therapy in Chronic Rheumatoid Arthritis: A Critical Study of
Homeopathy.
British Homoeopathic Journal, 1980,
69: 121-133.
Cruchet: 1854;
L'Homéopathie et le choléra de
1854, résponses aux homéopathes en général et à M. Chargé
en particulier (= in Homeopathy and Cholera in 1854, Responses to
Homeopaths in General and to M. Chargé in Particular).
Marseille, 1854.
Mabit J.: 1835;
Observations sur l'homéopathie
(= Notes on homeopathy).
Paris Baillière, 1835.
Reilly D., Taylor M. A.,
Beattie N. G. M., Campbell J. H., MC Sharry C., Aitchison T. C.,
Carter R., Stevenson R. D.: 1994;
Is Evidence for Homeopathy
Reproducible ?
The Lancet, 1994, 344: 1601-1606.
Fisher P., Greenwood A.,
Huskisson E. C., Turner P., Belon P.: 1991;
Traitement homéopathique de la
fibromyalgie primaire: à propos de deux essais cliniques en
double insu (= Homeopathic Treatment of Primary Fibromyalgia: Two
Double-Blind Clinical Trials).
Homéopathie Francaise, 1991, 79, 4:
15-22.
Brigo B.: 1987;
Le traitement homéopathique de
la migraine: une etude de 60 cas controlée en double aveugle (=
Homeopathic Treatment of the Migraine: A study of 60 Cases,
Controlled in Double-Blind).
Journal of Ligua Homeopathic
International, 1987, 38: 18-25.
Ower R. M. N, Ives G.: 1982;
The Mustard Gas Experiments of
the British Homoeopathic Society 1942.
Proceedings of the XXXV
International homeopathic Congress, 1982, 258-269.
Gibson R. G., Gibson S. L. M.,
Mac Neill A. D., Gray G. H., Dick W. C., Buchanan W. W.: 1978;
Salicyclates and Homeopathy in
Rheumatoid Arthritis: Preliminary Observations.
British Journal of Clinical
Pharmacology, 1978, 6: 391-395.
Charge: 1855;
L'Homéopathie et ses detracteurs
à l'occasion de l'épidémie de choléra qui a régné à
Marseille en 1854 (= Homeopathy and its Detractors, Concerning
the Cholera Epidemic of Marseille in 1854).
Paris Baillière, 1855.
Mabit J.: 1832;
Rapport sur le choléra morbus
asiatique qui a eté observé à Bordeaux depuis le 4 août 1832
jusqu'à ce jour et sur la nécessité du complet assainissement
de la ville (= Report on Asian Cholera Morbus which Was Observed
in Bordeaux from Aug 4, 1832 Until Today, and on the Necessity of
Draining og the City).
Bordeaux, Imprimerie Peletingeas,
1832.
Zicari D., Ricciotti F.,
Vingolo E. M., Zicari N.: 1992;
Valutazione dell'azione
angioprotettiva di preparati de arnica nel trattamento della
retinopatia diabetica (= Evaluation of the Angio-Protective
Effect of Preparations of Arnica in the Treatment of Diabetic
Retinopathy).
Bolentino de Oculistica, 1992, 5:
841-848.
Fisher P., Greenwood A.,
Huskisson E. C., Turner P., Belon P.: 1989;
Effect of homeopathic Treatment
on Fibrosis (Primary Fibromyalgia).
British Medical Journal 1989, 299:
365-366.
Turner P.: 1987;
Editorial.
Human Toxicology, 1987, 6: 267-268.
Gibson R. G., Gibson S. L. M.,
Mac Neill A. D., Buchanan W.W.: 1980;
Homeopathic Therapy in Rheumatoid
Arthritis: Evaluation by Double-Blind Clinical Therapeutic Trail.
British Journal of Clinical
Pharmacology, 1980, 9: 453-459.
Paterson J.: 1944;
Report on Mustard Gas Experiments
(Glasgow and London).
Journal of the American Institute of
Homeopathy, 1944, 37: 47-50, 88-92.
Chevallier L. et al:
Le choléra, la première
épidémie du XIXème siècle (= Cholera, The Foremost Epidemic
of the 19th Century).
Societé d'Histoire de la
Révolution de 1848. La Roche sur Yon: Imprimerie Centrale de
l'Quest, t 20.
Anden vigtig forskning
Eisenberg D. M., Kessler R. C.,
Foster C., Norlock F. E., Calkins D. R & Delbanco T. L.:
1993;
Unconventional Medicine in the
United States: Prevalence, Costs and Patterns of Use.
The New England Journal of Medicine,
1993, 328: 246-252.
Berkowitz C. D.: 1994;
Homoeopathy: Keeping an open
mind.
The Lancet, 1994, 344, 701-702.
In the Department of Health's Northern Ireland CAM
Pilot study 2008:
Patients receiving homeopathic treatment reported an average 54%
improvement in their health and well being, often after long
standing conventional treatment had failed.
10 out of 12 GPs surveyed had a more positive view of the
potential for CAM within primary care, with all wishing to
continue with the option of referring their patients to CAM.
In 99% of patient cases, the GP said that they would be willing
to refer the same patient, or another patient, to the Get Well UK
service.
In 98% of patient cases, the GP said they would be willing to
recommend the service to another GP.
Evaluation of a CAM Pilot Project in Northern Ireland (2008)
D McDade2008
Observational study Bristol Homeopathic Hospital.
Over 23,000 patient attendances in a 6-year period, 70% of
patients reported improved health, 50% major improvement of wide
range of conditions.
Spence DS, Thompson EA, Barron SJ (2005). Homeopathic treatment
for chronic disease: a 6-year university-hospital outpatient
observational study. Journal of Alternative and Complementary
Medicine, 11:793-798.
Sharples F, van Haselen R, Fisher P (2003).
NHS patients' perspective on complementary medicine: a
survey.
Complementary Therapies in Medicine, 11:243-248
500-patient survey at the RLHH showed many patients were able to
reduce or stop conventional medication following homeopathic
treatment.
Thompson EA, et al (2008).
Towards standard setting for patient-reported outcomes in
the NHS homeopathic hospitals.
Homeopathy, 97:114-121.
Pilot study published 2008. 1602 follow-up patient appointments
for 235 separate medical complaints at all five NHS homeopathic
hospitals collected together over one-month period.. Many
patients had multiple pathologies. 34% of patients reported an
improvement that affected their daily living after 2
appointments. After six appointments 59% reported improvement.
Richardson WR.(2001)
Patient benefit survey: Liverpool Regional Department of
Homeopathic medicine.
British Homeopathic Journal 90 158-162.
Outcome survey at the Liverpool department of homeopathic
medicine over a 12 month period in 1999-2000.
1100 patients; 76.6% reported an improvement and 60.3% reported
major improvement. 52% of 814 patients taking conventional
treatment were able to reduce or stop conventional medication.
Homeopathy and acupuncture backed for NHS funding.
Pulse magazine for GPs
Pulse.co.uk 17 Feb 2009
